Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Senior Vice President | December 06, 2013 | February 04, 2013 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date December 06, 2013 · Filed February 04, 2013
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 79,747 |
Ending reported balance
After 2012-12-07 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2012-12-06 · Gift · Disposed 7,700 · Balance 83,447 Row 2 · 2012-12-07 · Gift · Disposed 3,700 · Balance 79,747 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 07, 2012 Filed Feb 4, 2013 22:54 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 3,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-13-001806 · edgar.xml · nonDerivative · entry 2 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,747 Read SEC document |
| December 06, 2012 Filed Feb 4, 2013 22:54 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 7,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-13-001806 · edgar.xml · nonDerivative · entry 1 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,447 Read SEC document |
| May 08, 2012 Filed May 10, 2012 22:40 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 49,235 | $0.00 Strike: $33.76 | $0.00 |
DisclosureSEC source: 0001179110-12-008199 · edgar.xml · derivative · entry 16 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 49,235 shares Expires 2013-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Fully vested employee stock option received pursuant to the Agreement and Plan of Merger, dated January 11, 2009, by and among Abbott Laboratories, Rainforest Acquisition Inc. and Advanced Medical Optics, Inc. in exchange for an employee stock option to acquire 120,000 shares of Advanced Medical Optics, Inc. common stock for $13.85 per share. Read SEC document |
| May 08, 2012 Filed May 10, 2012 22:40 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 700 | $62.63 | $43,841.00 |
DisclosureSEC source: 0001179110-12-008199 · edgar.xml · nonDerivative · entry 15 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,147 Read SEC document |
| May 08, 2012 Filed May 10, 2012 22:40 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 600 | $62.62 | $37,572.00 |
DisclosureSEC source: 0001179110-12-008199 · edgar.xml · nonDerivative · entry 14 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,847 Read SEC document |
| May 08, 2012 Filed May 10, 2012 22:40 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,600 | $62.61 | $100,176.00 |
DisclosureSEC source: 0001179110-12-008199 · edgar.xml · nonDerivative · entry 13 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,447 Read SEC document |
| May 08, 2012 Filed May 10, 2012 22:40 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 519 | $62.60 | $32,489.40 |
DisclosureSEC source: 0001179110-12-008199 · edgar.xml · nonDerivative · entry 12 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,047 Read SEC document |
| May 08, 2012 Filed May 10, 2012 22:40 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 400 | $62.59 | $25,036.00 |
DisclosureSEC source: 0001179110-12-008199 · edgar.xml · nonDerivative · entry 11 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,566 Read SEC document |
| May 08, 2012 Filed May 10, 2012 22:40 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 800 | $62.58 | $50,064.00 |
DisclosureSEC source: 0001179110-12-008199 · edgar.xml · nonDerivative · entry 10 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,966 Read SEC document |
| May 08, 2012 Filed May 10, 2012 22:40 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 4,197 | $62.57 | $262,606.29 |
DisclosureSEC source: 0001179110-12-008199 · edgar.xml · nonDerivative · entry 9 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,766 Read SEC document |
| May 08, 2012 Filed May 10, 2012 22:40 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 400 | $62.56 | $25,024.00 |
DisclosureSEC source: 0001179110-12-008199 · edgar.xml · nonDerivative · entry 8 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,963 Read SEC document |
| May 08, 2012 Filed May 10, 2012 22:40 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,400 | $62.55 | $150,120.00 |
DisclosureSEC source: 0001179110-12-008199 · edgar.xml · nonDerivative · entry 7 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,363 Read SEC document |
| May 08, 2012 Filed May 10, 2012 22:40 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 4,719 | $62.54 | $295,126.26 |
DisclosureSEC source: 0001179110-12-008199 · edgar.xml · nonDerivative · entry 6 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,763 Read SEC document |
| May 08, 2012 Filed May 10, 2012 22:40 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 4,200 | $62.53 | $262,626.00 |
DisclosureSEC source: 0001179110-12-008199 · edgar.xml · nonDerivative · entry 5 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,482 Read SEC document |
| May 08, 2012 Filed May 10, 2012 22:40 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 11,000 | $62.52 | $687,720.00 |
DisclosureSEC source: 0001179110-12-008199 · edgar.xml · nonDerivative · entry 4 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,682 Read SEC document |
| May 08, 2012 Filed May 10, 2012 22:40 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 17,600 | $62.51 | $1,100,176.00 |
DisclosureSEC source: 0001179110-12-008199 · edgar.xml · nonDerivative · entry 3 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,682 Read SEC document |
| May 08, 2012 Filed May 10, 2012 22:40 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $62.50 | $6,250.00 |
DisclosureSEC source: 0001179110-12-008199 · edgar.xml · nonDerivative · entry 2 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,282 Read SEC document |
| May 08, 2012 Filed May 10, 2012 22:40 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 49,235 | $33.76 | $1,662,173.60 |
DisclosureSEC source: 0001179110-12-008199 · edgar.xml · nonDerivative · entry 1 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,382 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 29, 2012 Filed Mar 2, 2012 22:21 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 29 | $56.69 | $1,644.10 |
DisclosureSEC source: 0001179110-12-004083 · edgar.xml · nonDerivative · entry 3 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,147 Read SEC document |
| February 29, 2012 Filed Mar 2, 2012 22:21 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 625 | $56.69 | $35,432.50 |
DisclosureSEC source: 0001179110-12-004083 · edgar.xml · nonDerivative · entry 2 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,176 Read SEC document |
| February 29, 2012 Filed Mar 2, 2012 22:21 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 6,383 | $57.04 | $364,086.32 |
DisclosureSEC source: 0001179110-12-004083 · edgar.xml · nonDerivative · entry 1 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,801 Read SEC document |
| February 27, 2012 Filed Feb 28, 2012 22:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,000 | $56.61 | $56,613.00 |
DisclosureSEC source: 0001179110-12-003738 · edgar.xml · nonDerivative · entry 2 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,184 Read SEC document |
| February 26, 2012 Filed Feb 28, 2012 22:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 3,668 | $56.70 | $207,975.60 |
DisclosureSEC source: 0001179110-12-003738 · edgar.xml · nonDerivative · entry 1 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,184 Read SEC document |
| February 17, 2012 Filed Feb 22, 2012 23:15 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 22,000 | $0.00 Strike: $56.26 | $0.00 |
DisclosureSEC source: 0001179110-12-003259 · edgar.xml · derivative · entry 2 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Underlying: Common shares · 22,000 shares Expires 2022-02-16 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 7,334 on 02/17/2013, 7,333 on 02/17/2014, and 7,333 on 02/17/2015. Read SEC document |
| February 17, 2012 Filed Feb 22, 2012 23:15 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 12,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-12-003259 · edgar.xml · nonDerivative · entry 1 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,852 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 98,470 | $0.00 Strike: $21.92 | $0.00 |
DisclosureSEC source: 0001179110-11-014485 · edgar.xml · derivative · entry 31 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 98,470 shares Expires 2012-07-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option received pursuant to the Agreement and Plan of Merger dated January 11, 2009, by and among Abbott Laboratories, Rainforest Acquisition Inc. and Advanced Medical Optics, Inc. in exchange for an employee stock option to acquire 240,000 shares of Advanced Medical Optics, Inc. common stock for $8.99 per share. Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 400 | $53.41 | $21,362.00 |
DisclosureSEC source: 0001179110-11-014485 · edgar.xml · nonDerivative · entry 30 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,733 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,400 | $53.40 | $128,160.00 |
DisclosureSEC source: 0001179110-11-014485 · edgar.xml · nonDerivative · entry 29 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,133 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,500 | $53.40 | $80,092.50 |
DisclosureSEC source: 0001179110-11-014485 · edgar.xml · nonDerivative · entry 28 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,533 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,945 | $53.39 | $103,843.55 |
DisclosureSEC source: 0001179110-11-014485 · edgar.xml · nonDerivative · entry 27 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,033 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $53.38 | $10,676.00 |
DisclosureSEC source: 0001179110-11-014485 · edgar.xml · nonDerivative · entry 26 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,978 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $53.37 | $10,674.00 |
DisclosureSEC source: 0001179110-11-014485 · edgar.xml · nonDerivative · entry 25 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,178 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,700 | $53.36 | $90,712.00 |
DisclosureSEC source: 0001179110-11-014485 · edgar.xml · nonDerivative · entry 24 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,378 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,475 | $53.35 | $132,041.25 |
DisclosureSEC source: 0001179110-11-014485 · edgar.xml · nonDerivative · entry 23 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,078 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 4,047 | $53.34 | $215,866.98 |
DisclosureSEC source: 0001179110-11-014485 · edgar.xml · nonDerivative · entry 22 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,553 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $53.34 | $5,333.90 |
DisclosureSEC source: 0001179110-11-014485 · edgar.xml · nonDerivative · entry 21 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,600 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 900 | $53.34 | $48,001.50 |
DisclosureSEC source: 0001179110-11-014485 · edgar.xml · nonDerivative · entry 20 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,700 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 3,800 | $53.33 | $202,654.00 |
DisclosureSEC source: 0001179110-11-014485 · edgar.xml · nonDerivative · entry 19 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,600 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,200 | $53.33 | $63,990.00 |
DisclosureSEC source: 0001179110-11-014485 · edgar.xml · nonDerivative · entry 18 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,400 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,500 | $53.32 | $79,980.00 |
DisclosureSEC source: 0001179110-11-014485 · edgar.xml · nonDerivative · entry 17 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,600 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 800 | $53.32 | $42,652.00 |
DisclosureSEC source: 0001179110-11-014485 · edgar.xml · nonDerivative · entry 16 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,100 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 6,196 | $53.31 | $330,308.76 |
DisclosureSEC source: 0001179110-11-014485 · edgar.xml · nonDerivative · entry 15 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,900 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $53.31 | $5,330.70 |
DisclosureSEC source: 0001179110-11-014485 · edgar.xml · nonDerivative · entry 14 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,096 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,000 | $53.31 | $53,305.00 |
DisclosureSEC source: 0001179110-11-014485 · edgar.xml · nonDerivative · entry 13 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,196 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 4,100 | $53.30 | $218,530.00 |
DisclosureSEC source: 0001179110-11-014485 · edgar.xml · nonDerivative · entry 12 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,196 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 300 | $53.30 | $15,988.50 |
DisclosureSEC source: 0001179110-11-014485 · edgar.xml · nonDerivative · entry 11 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,296 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,800 | $53.29 | $149,212.00 |
DisclosureSEC source: 0001179110-11-014485 · edgar.xml · nonDerivative · entry 10 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,596 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,300 | $53.29 | $69,270.50 |
DisclosureSEC source: 0001179110-11-014485 · edgar.xml · nonDerivative · entry 9 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,396 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,226 | $53.28 | $65,321.28 |
DisclosureSEC source: 0001179110-11-014485 · edgar.xml · nonDerivative · entry 8 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,696 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $53.28 | $10,655.00 |
DisclosureSEC source: 0001179110-11-014485 · edgar.xml · nonDerivative · entry 7 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,922 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.